Xiaolong Cheng

912 total citations
35 papers, 572 citations indexed

About

Xiaolong Cheng is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Xiaolong Cheng has authored 35 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in Xiaolong Cheng's work include MicroRNA in disease regulation (4 papers), CRISPR and Genetic Engineering (4 papers) and Single-cell and spatial transcriptomics (3 papers). Xiaolong Cheng is often cited by papers focused on MicroRNA in disease regulation (4 papers), CRISPR and Genetic Engineering (4 papers) and Single-cell and spatial transcriptomics (3 papers). Xiaolong Cheng collaborates with scholars based in China, United States and Australia. Xiaolong Cheng's co-authors include Wei Li, Yuqing Zhu, Victor X. Jin, Zexu Li, Huirong Liu, Xiaoliang Wang, Leilei Chen, Siyu Su, Tim H.‐M. Huang and Hua Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Xiaolong Cheng

29 papers receiving 569 citations

Peers

Xiaolong Cheng
Chanabasayya Vastrad India
Basavaraj Vastrad India
Laura Spruill United States
Nan Chen China
Jianfeng Huang China
Ge Wu China
Aurelia Vattai Germany
Xeni Provatopoulou Greece
Naiara G. Bediaga Australia
Si Yang China
Chanabasayya Vastrad India
Xiaolong Cheng
Citations per year, relative to Xiaolong Cheng Xiaolong Cheng (= 1×) peers Chanabasayya Vastrad

Countries citing papers authored by Xiaolong Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Cheng more than expected).

Fields of papers citing papers by Xiaolong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Cheng. The network helps show where Xiaolong Cheng may publish in the future.

Co-authorship network of co-authors of Xiaolong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Cheng. A scholar is included among the top collaborators of Xiaolong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Cheng. Xiaolong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Mingchang, S. S. Shi, Xiaolong Cheng, et al.. (2025). π-π conjugated MOF/nano-carbon complexes: Synergistic Ion transport and redox pathways for fast zinc-ion storage. Materials Today Energy. 53. 102041–102041.
2.
3.
Liu, Jingwei, Xiaolong Cheng, Xinyi Chen, et al.. (2025). The construction of one-dimensional chain-like coordination polymers and their applications in anode materials for lithium-ion batteries. CrystEngComm. 27(37). 6193–6201.
4.
5.
Wang, Lu, Huijuan Liu, Yiqian Liu, et al.. (2024). Potential markers of cancer stem-like cells in ESCC: a review of the current knowledge. Frontiers in Oncology. 13. 1324819–1324819. 2 indexed citations
6.
Wang, Xudong, Siyu Su, Yuqing Zhu, et al.. (2023). Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors. Nature Communications. 14(1). 5778–5778. 81 indexed citations
7.
8.
Yao, Yingjia, Yunhan Zhang, Zexu Li, et al.. (2023). A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism. Biochemical and Biophysical Research Communications. 675. 113–121. 2 indexed citations
9.
Qu, Jia, et al.. (2023). A new integrated framework for the identification of potential virus–drug associations. Frontiers in Microbiology. 14. 1179414–1179414. 5 indexed citations
10.
Cheng, Xiaolong, Zexu Li, Zihan Li, et al.. (2023). Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches. Nature Communications. 14(1). 752–752. 38 indexed citations
11.
Zhang, Dongli, et al.. (2023). Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures. Urologia Internationalis. 107(9). 841–847.
12.
Li, Zexu, Yingjia Yao, Xiaolong Cheng, et al.. (2021). A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses. iScience. 24(3). 102148–102148. 13 indexed citations
13.
Li, Zexu, Yingjia Yao, Xiaolong Cheng, Wei Li, & Fei Teng. (2021). An in silico drug repositioning workflow for host-based antivirals. STAR Protocols. 2(3). 100653–100653. 2 indexed citations
14.
Zhou, Yufan, Xiaolong Cheng, Li Tian, et al.. (2020). Modeling and analysis of Hi-C data by HiSIF identifies characteristic promoter-distal loops. Genome Medicine. 12(1). 69–69. 7 indexed citations
15.
Yang, Lin, Yuqing Zhu, Hua Yu, et al.. (2020). scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens. Genome biology. 21(1). 19–19. 54 indexed citations
16.
Zhang, Ling, Ruyi Shi, Caixia Cheng, et al.. (2013). Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Cancer Letters. 337(1). 125–132. 14 indexed citations
17.
Lu, Li, Huifang Song, Weiguo Zhang, et al.. (2012). Potential role of 20S proteasome in maintaining stem cell integrity of human bone marrow stromal cells in prolonged culture expansion. Biochemical and Biophysical Research Communications. 422(1). 121–127. 18 indexed citations
18.
Cheng, Xiaolong, et al.. (2010). Portal vein aneurysms with multiple associated findings. VASA. 39(4). 312–318. 5 indexed citations
19.
Shen, Yang, Shuchen Li, Ling Zheng, Xiaodong Ren, & Xiaolong Cheng. (2009). Emotion mining research on micro-blog. 71–75. 24 indexed citations
20.
Yang, Xiaoli, Feng Wang, Suli Zhang, et al.. (2008). Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. Journal of Hypertension. 26(8). 1629–1635. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chanabasayya Vastrad Breakdown of academic impact, for papers by Basavaraj Vastrad Breakdown of academic impact, for papers by Laura Spruill Breakdown of academic impact, for papers by Nan Chen Breakdown of academic impact, for papers by Jianfeng Huang Breakdown of academic impact, for papers by Ge Wu Breakdown of academic impact, for papers by Aurelia Vattai Breakdown of academic impact, for papers by Xeni Provatopoulou Breakdown of academic impact, for papers by Naiara G. Bediaga Breakdown of academic impact, for papers by Si Yang
Rankless by CCL
2026